⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4823616 | 0.88 | — | — | |
| Potassium Ion SCHEMBL553768 | 0.88 | SLC34A1 (0.32) | — | |
| SCHEMBL7860312 | 0.88 | — | — | |
| SCHEMBL553542 | 0.88 | — | — | |
| Lithium Ion SCHEMBL21749348 | 0.88 | — | — | |
| SCHEMBL920065 | 0.88 | — | — | |
| Silver SCHEMBL555009 | 0.88 | — | — | |
| Water SCHEMBL28672424 | 0.86 | SLC34A1 (0.30) | — | |
| SCHEMBL20362526 | 0.74 | LMNA (0.54) | — | |
| Tetrabuthylammonium SCHEMBL909400 | 0.74 | SLC22A1 (0.46) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 51 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12071421-B2 | Process for the synthesis of substituted chloromethyl dialkylphosphates | HELSINN HEALTHCARE SA (CH) | 2024-08-27 | — | — | US | disclosed |
| US-20220401463-A1 | SUBSTITUTED 4-PHENYL-PYRIDINES | HELSINN HEALTHCARE SA (CH) | 2022-12-22 | — | — | US | disclosed |
| US-11312698-B2 | Fosnetupitant chloride hydrochloride having improved stability | HELSINN HEALTHCARE SA (CH) | 2022-04-26 | — | — | US | disclosed |
| US-20200399240-A1 | SUBSTITUTED 4-PHENYL-PYRIDINES | HELSINN HEALTHCARE SA (CH) | 2020-12-24 | — | — | US | disclosed |
| EP-3217980-B1 | CICLOPIROX, CICLOPIROX OLAMINE, OR A CICLOPIROX PRODRUG FOR USE IN THE TREATMENT OF BLADDER CANCER | UNIV KANSAS (US) | 2020-10-14 | — | — | EP | disclosed |
| US-10717721-B2 | Substituted piperaziniums for the treatment of emesis | HELSINN HEALTHCARE SA (CH) | 2020-07-21 | — | — | US | disclosed |
| US-20190177296-A1 | SOLUTION COMPRISING THE CHLORIDE HYDROCHLORIDE SALT OF 4-(5-(2-(3,5-BIS(TRIFLUOROMETHYL)PHENYL)-N,2-DIMETHYLPROPANAMIDO)-4-(o-TOLYL)PYRIDIN-2-YL)-1-METHYL-1-((PHOSPHONOOXY)METHYL)PIPERAZIN-1-IUM (FOSNETUPITANT) AND PALONOSETRON HYDROCHLORIDE IN COMBINATION WITH DEXAMETHASONE AS A NEUROKININ RECEPTOR MODULATOR | HELSINN HEALTHCARE SA (CH) | 2019-06-13 | — | — | US | disclosed |
| US-10239842-B2 | Hydrosoluble compounds derived from benzimidazole used in treating fasciolosis | UNIVERSIDAD NACIONAL AUTONOMA DE MEXICO (MX) | 2019-03-26 | — | — | US | disclosed |
| US-10208073-B2 | Solution comprising the chloride hydrochloride salt of 4-(5-(2-(3,5-bis(trifluoromethyl)phenyl)-N,2-dimethylpropanamido)-4-(o-tolyl)pyridin-2-yl)-1-methyl-1-((phosphonooxy)methyl)piperazin-1-IUM-(fosnetupitant) and palonosetron hydrochloride in combination with dexamethasone as a neurokinin receptor modulator | HELSINN HEALTHCARE SA (CH) | 2019-02-19 | — | — | US | disclosed |
| US-20180194788-A1 | SUBSTITUTED 4-PHENYL-PYRIDINES | HELSINN HEALTHCARE SA (CH) | 2018-07-12 | — | — | US | disclosed |
| US-20090075998-A1 | 2-(phenyl or heterocyclic)-1H-phenantrho[9,10-d]imidazoles as mPGES-1 inhibitors | MERCK CANADA INC. (CA) | 2009-03-19 | — | — | US | disclosed |
| EP-2019675-A1 | METHODS FOR TREATING OR PREVENTING NEOPLASIAS | Merck Frosst Canada Ltd. (CA) | 2009-02-04 | — | — | EP | disclosed |
| US-7442716-B2 | 2-(phenyl or heterocyclic)-1H-phenantrho[9,10-d]imidazoles as mPGES-1 inhibitors | MERCK FROSST CANADA LTD. (CA) | 2008-10-28 | — | — | US | disclosed |
| WO-2007124589-A1 | METHODS FOR TREATING OR PREVENTING NEOPLASIAS | MERCK FROSST CANADA LTD. (CA) | 2007-11-08 | — | — | WO | disclosed |
| US-20070208017-A1 | 2-(Phenyl or heterocyclic)-1H-phenantrho[9,10-d]imidazoles as mPGES-1 inhibitors | MERCK CANADA INC. (CA) | 2007-09-06 | — | — | US | disclosed |
| EP-1051181-B1 | WATER SOLUBLE PRODRUGS OF TERTIARY AMINE CONTAINING DRUGS AND METHODS OF MAKING THEREOF | UNIV KANSAS (US) | 2004-03-17 | — | — | EP | disclosed |
| EP-1051181-A2 | WATER SOLUBLE PRODRUGS OF SECONDARY AND TERTIARY AMINE CONTAINING DRUGS AND METHODS OF MAKING THEREOF | THE UNIVERSITY OF KANSAS (US) | 2000-11-15 | — | — | EP | disclosed |
| US-5985856-A | N-PHOSPHORYLOXYMETHYL PRODRUGS OF SECONDARY AND TERTIARY AMINE CONTAINING DRUGS | UNIVERSITY OF KANSAS (US) | 1999-11-16 | — | — | US | disclosed |
| WO-1999033846-A2 | WATER SOLUBLE PRODRUGS OF SECONDARY AND TERTIARY AMINE CONTAINING DRUGS AND METHODS OF MAKING THEREOF | THE UNIVERSITY OF KANSAS (US) | 1999-07-08 | — | — | WO | disclosed |
| US-4185111-A | Daunorubicin derivatives | RHONE-POULENC INDUSTRIES (FR) | 1980-01-22 | — | — | US | disclosed |